SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-034213
Filing Date
2017-02-08
Accepted
2017-02-08 12:02:32
Documents
2
Group Members
CALEB WINDEREXCEL VENTURES II GP, LLCFREDERICK R. BLUMEJUAN ENRIQUEZSTEVEN R. GULLANS

Document Format Files

Seq Description Document Type Size
1 SC 13G d235461dsc13g.htm SC 13G 113340
2 EX-99.1 d235461dex991.htm EX-99.1 5738
  Complete submission text file 0001193125-17-034213.txt   120767
Mailing Address 800 BOYLSTON STREET, PRUDENTIAL TOWER BOSTON MA 02199
Business Address 800 BOYLSTON STREET, PRUDENTIAL TOWER BOSTON MA 02199 (617) 450-9800
Excel Venture Fund II, L.P. (Filed by) CIK: 0001538240 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89598 | Film No.: 17581540
SIC: 2834 Pharmaceutical Preparations